NAPLES, Fla. and STAMFORD, Conn. — November 5, 2025 — Leads & Copy — Naples Comprehensive Health’s Rooney Heart Institute is the first hospital in the U.S. to use CaRi-Plaque™ and CaRi-Heart®, two AI technologies that identify heart disease signs and predict heart attack risk up to 10 years early.
The collaboration with Caristo Diagnostics shifts focus from reacting to preventing cardiovascular disease. Caristo’s FDA-cleared CaRi-Plaque™ analyzes coronary CT angiography scans to identify high-risk plaque. CaRi-Heart™ detects and quantifies coronary inflammation, an early driver of heart disease, without waiting for plaque development.
The AHA Scientific Sessions 2025 will feature Drs. Orringer and Wang discussing AI’s impact on coronary disease detection and management.
Dee Dee Wang, MD, Section Head of Cardiac Imaging at NCH Rooney Heart Institute.
Carl E. Orringer, MD, Director of Preventive Cardiology, NCH Rooney Heart Institute.
Source: Naples Comprehensive Health
Source: Naples Comprehensive Health
